These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 32900251)
61. Development of Acyclovir-Loaded Albumin Nanoparticles and Improvement of Acyclovir Permeation Across Human Corneal Epithelial T Cells. Suwannoi P; Chomnawang M; Sarisuta N; Reichl S; Müller-Goymann CC J Ocul Pharmacol Ther; 2017 Dec; 33(10):743-752. PubMed ID: 29111864 [TBL] [Abstract][Full Text] [Related]
62. Cholesterol-conjugated bovine serum albumin nanoparticles as a tamoxifen tumor-targeted delivery system. Gharbavi M; Johari B; Eslami SS; Mousazadeh N; Sharafi A Cell Biol Int; 2020 Dec; 44(12):2485-2498. PubMed ID: 32841441 [TBL] [Abstract][Full Text] [Related]
63. Synthesis and correction of albumin magnetic nanoparticles with organic compounds for absorbing and releasing doxorubicin hydrochloride. Hormozi N; Esmaeili A Colloids Surf B Biointerfaces; 2019 Oct; 182():110368. PubMed ID: 31362156 [TBL] [Abstract][Full Text] [Related]
64. Impact of surface modification in BSA nanoparticles for uptake in cancer cells. Choi JS; Meghani N Colloids Surf B Biointerfaces; 2016 Sep; 145():653-661. PubMed ID: 27289306 [TBL] [Abstract][Full Text] [Related]
65. Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy. Maji R; Dey NS; Satapathy BS; Mukherjee B; Mondal S Int J Nanomedicine; 2014; 9():3107-18. PubMed ID: 25028549 [TBL] [Abstract][Full Text] [Related]
66. Coordination bonding based pH-responsive albumin nanoparticles for anticancer drug delivery. Li C; Xing L; Che S Dalton Trans; 2012 Apr; 41(13):3714-9. PubMed ID: 22370556 [TBL] [Abstract][Full Text] [Related]
67. Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue. Gawde KA; Kesharwani P; Sau S; Sarkar FH; Padhye S; Kashaw SK; Iyer AK J Colloid Interface Sci; 2017 Jun; 496():290-299. PubMed ID: 28236692 [TBL] [Abstract][Full Text] [Related]
68. Doughnut-shaped bovine serum albumin nanoparticles loaded with doxorubicin for overcoming multidrug-resistant in cancer cells. Kayani Z; Firuzi O; Bordbar AK Int J Biol Macromol; 2018 Feb; 107(Pt B):1835-1843. PubMed ID: 29030194 [TBL] [Abstract][Full Text] [Related]
69. β-cyclodextrin-poly(β-amino ester) nanoparticles for sustained drug delivery across the blood-brain barrier. Gil ES; Wu L; Xu L; Lowe TL Biomacromolecules; 2012 Nov; 13(11):3533-41. PubMed ID: 23066958 [TBL] [Abstract][Full Text] [Related]
70. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base. Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421 [TBL] [Abstract][Full Text] [Related]
71. Glucose-conjugated glutenin nanoparticles for selective targeting and delivery of camptothecin into breast cancer cells. Rajeshkumar RR; Pavadai P; Panneerselvam T; Deepak V; Pandian SRK; Kabilan SJ; Vellaichamy S; Jeyaraman A; Kumar ASK; Sundar K; Kunjiappan S Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2571-2586. PubMed ID: 37022437 [TBL] [Abstract][Full Text] [Related]
72. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery. Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723 [TBL] [Abstract][Full Text] [Related]
73. Characterization and evaluation of 5-fluorouracil-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification technique. Patel MN; Lakkadwala S; Majrad MS; Injeti ER; Gollmer SM; Shah ZA; Boddu SH; Nesamony J AAPS PharmSciTech; 2014 Dec; 15(6):1498-508. PubMed ID: 25035070 [TBL] [Abstract][Full Text] [Related]
74. Folate-functionalized nanoparticles for controlled ergosta-4,6,8(14),22-tetraen-3-one delivery. Liang X; Sun Y; Liu L; Ma X; Hu X; Fan J; Zhao Y Int J Pharm; 2013 Jan; 441(1-2):1-8. PubMed ID: 23262423 [TBL] [Abstract][Full Text] [Related]
75. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor. Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181 [TBL] [Abstract][Full Text] [Related]
76. Effect of structure in ionised albumin based nanoparticle: Characterisation, Emodin interaction, and in vitro cytotoxicity. Siri M; Ruocco MJF; Achilli E; Pizzuto M; Delgado JF; Ruysschaert JM; Grasselli M; Alonso SDV Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109813. PubMed ID: 31349435 [TBL] [Abstract][Full Text] [Related]
77. Modification of paclitaxel-loaded solid lipid nanoparticles with 2-hydroxypropyl-β-cyclodextrin enhances absorption and reduces nephrotoxicity associated with intravenous injection. Baek JS; Kim JH; Park JS; Cho CW Int J Nanomedicine; 2015; 10():5397-405. PubMed ID: 26347363 [TBL] [Abstract][Full Text] [Related]
78. Characterization of solid lipid nanoparticles containing caffeic acid and determination of its effects on MCF-7 cells. Dikmen G; Guney G; Genc L Recent Pat Anticancer Drug Discov; 2015; 10(2):224-32. PubMed ID: 25619199 [TBL] [Abstract][Full Text] [Related]
79. Optimization of physicochemical parameters influencing the fabrication of protein-loaded chitosan nanoparticles. Vandana M; Sahoo SK Nanomedicine (Lond); 2009 Oct; 4(7):773-85. PubMed ID: 19839813 [TBL] [Abstract][Full Text] [Related]
80. Tuning the binding, release and cytotoxicity of hydrophobic drug by Bovine Serum Albumin nanoparticles: Influence of particle size. Das RP; Singh BG; Kunwar A; Ramani MV; Subbaraju GV; Hassan PA; Priyadarsini KI Colloids Surf B Biointerfaces; 2017 Oct; 158():682-688. PubMed ID: 28783613 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]